Momenta Pharmaceuticals, Inc. announced that pursuant to the Merger Agreement, at the Effective Time, on October 1, 2020, each of the members of the board of directors of the Company prior to the Effective Time ceased to be members of the board of directors of the Company, and the members of the board of directors of Merger Sub, consisting of Susan Hohenleitner, Duane Van Arsdale and Jonathan Bryant, became the members of the board of directors of the Company. In addition, on September 30, 2020, Craig A. Wheeler notified the Company of his intent to resign as the Company's President and Chief Executive Officer following the closing of the Merger, effective upon a future date to be agreed upon by Mr. Wheeler and the Company.